Sato, M., Nakai, Y., Nakata, W., Yoshida, T., Hatano, K., Kawashima, A., . . . Nonomura, N. (2013). EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. Public Library of Science (PLoS).
Style de citation Chicago (17e éd.)Sato, Mototaka, et al. EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome. Public Library of Science (PLoS), 2013.
Style de citation MLA (8e éd.)Sato, Mototaka, et al. EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome. Public Library of Science (PLoS), 2013.
Attention : ces citations peuvent ne pas être correctes à 100%.